Reactive Metabolites and AGE-RAGE-Mediated Inflammation in Patients following Liver Transplantation

Table 1

Baseline data of 150 patients undergoing liver transplantation (LTPL) from deceased donors.

Baseline data
Urgency
Nonurgent	123 (82.0%)
High urgency (HU)	27 (18.0%)
Surgical specialties
First-time LTPL	121 (80.7%)
Re-LTPL	29 (19.3%)
Disease severity
Lab MELD score	21.5 (11.0–34.0)
Ischemia times^a
Cold ischemia time (CIT) (min)	685 (596–722)
Warm ischemia time (WIT) (min)	62 (50–80)
Primary liver diseases in patients undergoing first-time LTPL
(𝑛=121)
Ethyl-toxic cirrhosis	20 (16.5%)
Viral hepatitis	13 (10.7%)
Hepatocellular carcinoma (HCC)	36 (29.8%); Origin: viral hepatitis 18 (14.9%), ethyl-toxic cirrhosis 16 (13.2%), cryptogenic 2 (1.7%)
Others	52 (42.1%)

Data are presented as number (%) or as median with quartiles (Q1–Q3).
^aDefinitions: the CIT was defined as the period between donor aortic cross-clamping during organ procurement and graft removal from iced water at the recipient site.
The allograft rewarming time between graft removal from iced water at the recipient site and portal reperfusion was regarded as the WIT.